103 related articles for article (PubMed ID: 9421451)
1. The experience with neutron irradiation in locally advanced adenocarcinoma of the prostate.
Forman JD; Porter AT
Semin Urol Oncol; 1997 Nov; 15(4):239-43. PubMed ID: 9421451
[TBL] [Abstract][Full Text] [Related]
2. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
[TBL] [Abstract][Full Text] [Related]
3. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
Haraf DJ; Rubin SJ; Sweeney P; Kuchnir FT; Sutton HG; Chodak GW; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):3-14. PubMed ID: 7642429
[TBL] [Abstract][Full Text] [Related]
4. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
5. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
Hillman GG; Maughan RL; Grignon DJ; Yudelev M; Rubio J; Tekyi-Mensah S; Layer A; Che M; Forman JD
Clin Cancer Res; 2001 Jan; 7(1):136-44. PubMed ID: 11205901
[TBL] [Abstract][Full Text] [Related]
6. Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer.
Copp H; Bissonette EA; Theodorescu D
Urology; 2005 Jun; 65(6):1146-51. PubMed ID: 15922433
[TBL] [Abstract][Full Text] [Related]
7. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
8. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
[TBL] [Abstract][Full Text] [Related]
9. Fast neutron therapy at the end of 1988--a survey of the clinical data.
Wambersie A
Strahlenther Onkol; 1990 Jan; 166(1):52-60. PubMed ID: 2405533
[TBL] [Abstract][Full Text] [Related]
10. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
Cheung R; Tucker SL; Lee AK; de Crevoisier R; Dong L; Kamat A; Pisters L; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):993-1002. PubMed ID: 15752878
[TBL] [Abstract][Full Text] [Related]
11. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
Urology; 2004 Oct; 64(4):754-9. PubMed ID: 15491715
[TBL] [Abstract][Full Text] [Related]
12. Candidates for prostate radioactive seed implantation treated by external beam radiotherapy.
Seung SK; Kroll S; Wilder RB; Posner MD; Roach M
Cancer J Sci Am; 1998; 4(3):168-74. PubMed ID: 9612598
[TBL] [Abstract][Full Text] [Related]
13. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
14. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
[TBL] [Abstract][Full Text] [Related]
15. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.
Potters L; Cha C; Oshinsky G; Venkatraman E; Zelefsky M; Leibel S
Cancer J Sci Am; 1999; 5(5):301-6. PubMed ID: 10526671
[TBL] [Abstract][Full Text] [Related]
16. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
Lawton CA; Winter K; Grignon D; Pilepich MV
J Clin Oncol; 2005 Feb; 23(4):800-7. PubMed ID: 15681524
[TBL] [Abstract][Full Text] [Related]
17. Review of clinical results of fast neutron therapy in the USA.
Peters LJ; Maor MH; Laramore GE; Griffin TW; Hendrickson FR
Strahlentherapie; 1985 Dec; 161(12):731-8. PubMed ID: 4082208
[TBL] [Abstract][Full Text] [Related]
18. Salvage radiation for a rising PSA following radical prostatectomy.
Maier J; Forman J; Tekyi-Mensah S; Bolton S; Patel R; Pontes JE
Urol Oncol; 2004; 22(1):50-6. PubMed ID: 14969805
[TBL] [Abstract][Full Text] [Related]
19. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC.
Scalliet PG; Remouchamps V; Curran D; Ledent G; Wambersie A; Richard F; van Cangh P
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1549-61. PubMed ID: 15050336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
